Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
Clinical trial NCT05848128 · COMPLETED
Trial details
- NCT number
- NCT05848128
- Sponsor
- Mimetogen Pharmaceuticals USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-28
- Primary completion
- 2024-05-11
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.